Skip to main content
Premium Trial:

Request an Annual Quote

InforSense Makes GenSense Software Affy-Compatible

NEW YORK (GenomeWeb News) - InforSense said today that it has joined the Affymetrix GeneChip-compatible Applications Program in order to make its GenSense software compatible with the GeneChip platform.
 
Affymetrix has also become a member of InforSense's Open Workflow Partner Network, the company said.
 
InforSense said the integration will allow researchers to analyze and interpret information from Affy's Genome-Wide Human SNP 5.0 and SNP 6.0 arrays.
 
The company said its embedded analytics software now offers access to Affy's software for analyzing loss of heterozygosity and copy number variation, and several of Affy's calling algorithms, including BRLMM, BRLMM-p, and Birdseed.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.